ID   NUD10_HUMAN             Reviewed;         164 AA.
AC   Q8NFP7; A8K7D7; D3DX69; Q86VK1; Q86VR0;
DT   05-JUL-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2002, sequence version 1.
DT   10-MAY-2017, entry version 129.
DE   RecName: Full=Diphosphoinositol polyphosphate phosphohydrolase 3-alpha {ECO:0000303|PubMed:12105228};
DE            Short=DIPP-3-alpha;
DE            Short=DIPP3-alpha {ECO:0000303|PubMed:12105228};
DE            Short=hDIPP3alpha {ECO:0000303|PubMed:12105228};
DE            EC=3.6.1.52 {ECO:0000269|PubMed:12105228, ECO:0000269|PubMed:12121577, ECO:0000269|PubMed:12370170};
DE   AltName: Full=Diadenosine 5',5'''-P1,P6-hexaphosphate hydrolase 3-alpha;
DE   AltName: Full=Diadenosine hexaphosphate hydrolase (AMP-forming);
DE            EC=3.6.1.60 {ECO:0000269|PubMed:12105228, ECO:0000269|PubMed:12121577, ECO:0000269|PubMed:12370170};
DE   AltName: Full=Nucleoside diphosphate-linked moiety X motif 10;
DE            Short=Nudix motif 10;
DE   AltName: Full=hAps2;
GN   Name=NUDT10; Synonyms=APS2, DIPP3A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, CATALYTIC ACTIVITY,
RP   BIOPHYSICOCHEMICAL PROPERTIES, AND TISSUE SPECIFICITY.
RX   PubMed=12105228; DOI=10.1074/jbc.M205476200;
RA   Hidaka K., Caffrey J.J., Hua L., Zhang T., Falck J.R., Nickel G.C.,
RA   Carrel L., Barnes L.D., Shears S.B.;
RT   "An adjacent pair of human NUDT genes on chromosome X are
RT   preferentially expressed in testis and encode two new isoforms of
RT   diphosphoinositol polyphosphate phosphohydrolase.";
RL   J. Biol. Chem. 277:32730-32738(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, COFACTOR, BIOPHYSICOCHEMICAL
RP   PROPERTIES, AND TISSUE SPECIFICITY.
RX   PubMed=12121577; DOI=10.1186/1472-2091-3-20;
RA   Leslie N.R., McLennan A.G., Safrany S.T.;
RT   "Cloning and characterisation of hAps1 and hAps2, human diadenosine
RT   polyphosphate-metabolising Nudix hydrolases.";
RL   BMC Biochem. 3:20-20(2002).
RN   [7]
RP   CATALYTIC ACTIVITY.
RX   PubMed=12370170; DOI=10.1074/jbc.M209795200;
RA   Fisher D.I., Safrany S.T., Strike P., McLennan A.G., Cartwright J.L.;
RT   "Nudix hydrolases that degrade dinucleoside and diphosphoinositol
RT   polyphosphates also have 5-phosphoribosyl 1-pyrophosphate (PRPP)
RT   pyrophosphatase activity that generates the glycolytic activator
RT   ribose 1,5-bisphosphate.";
RL   J. Biol. Chem. 277:47313-47317(2002).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 17-144 IN COMPLEX WITH
RP   CITRATE.
RG   Structural genomics consortium (SGC);
RT   "Crystal structure of human diphosphoinositol polyphosphate
RT   phosphohydrolase 3-alpha.";
RL   Submitted (APR-2010) to the PDB data bank.
CC   -!- FUNCTION: Cleaves a beta-phosphate from the diphosphate groups in
CC       PP-InsP5 (diphosphoinositol pentakisphosphate), suggesting that it
CC       may play a role in signal transduction. Also able to catalyze the
CC       hydrolysis of dinucleoside oligophosphates, with Ap6A and Ap5A
CC       being the preferred substrates. The major reaction products are
CC       ADP and p4a from Ap6A and ADP and ATP from Ap5A. Also able to
CC       hydrolyze 5-phosphoribose 1-diphosphate.
CC       {ECO:0000269|PubMed:12105228}.
CC   -!- CATALYTIC ACTIVITY: Diphospho-myo-inositol polyphosphate + H(2)O =
CC       myo-inositol polyphosphate + phosphate.
CC       {ECO:0000269|PubMed:12105228, ECO:0000269|PubMed:12121577,
CC       ECO:0000269|PubMed:12370170}.
CC   -!- CATALYTIC ACTIVITY: P(1),P(6)-bis(5'-adenosyl)hexaphosphate +
CC       H(2)O = adenosine 5'-pentaphosphate + AMP.
CC       {ECO:0000269|PubMed:12105228, ECO:0000269|PubMed:12121577,
CC       ECO:0000269|PubMed:12370170}.
CC   -!- CATALYTIC ACTIVITY: P(1),P(5)-bis(5'-adenosyl)pentaphosphate +
CC       H(2)O = adenosine 5'-tetraphosphate + AMP.
CC       {ECO:0000269|PubMed:12105228, ECO:0000269|PubMed:12121577,
CC       ECO:0000269|PubMed:12370170}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250, ECO:0000269|PubMed:12121577};
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000250, ECO:0000269|PubMed:12121577};
CC       Note=Binds 3 Mg(2+) or Mn(2+) ions per subunit. Mn(2+) may be the
CC       true cofactor in vivo. {ECO:0000250, ECO:0000269|PubMed:12121577};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.088 uM for PP-InsP5 {ECO:0000269|PubMed:12105228,
CC         ECO:0000269|PubMed:12121577};
CC         KM=19 uM for Ap6A {ECO:0000269|PubMed:12105228,
CC         ECO:0000269|PubMed:12121577};
CC         KM=50 uM for Ap5A {ECO:0000269|PubMed:12105228,
CC         ECO:0000269|PubMed:12121577};
CC       pH dependence:
CC         Optimum pH is 8.5. {ECO:0000269|PubMed:12105228,
CC         ECO:0000269|PubMed:12121577};
CC   -!- INTERACTION:
CC       Q5JR59:MTUS2; NbExp=3; IntAct=EBI-726826, EBI-742948;
CC       O75971:SNAPC5; NbExp=3; IntAct=EBI-726826, EBI-749483;
CC       P15884:TCF4; NbExp=3; IntAct=EBI-726826, EBI-533224;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305|PubMed:12121577}.
CC   -!- TISSUE SPECIFICITY: Mainly expressed in testis and, at lower level
CC       in brain. According to PubMed:12121577, it is widely expressed.
CC       {ECO:0000269|PubMed:12105228, ECO:0000269|PubMed:12121577}.
CC   -!- SIMILARITY: Belongs to the Nudix hydrolase family. DIPP subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF469196; AAM64113.1; -; mRNA.
DR   EMBL; AK291952; BAF84641.1; -; mRNA.
DR   EMBL; AL158055; CAI40295.1; -; Genomic_DNA.
DR   EMBL; CH471180; EAW89910.1; -; Genomic_DNA.
DR   EMBL; CH471180; EAW89911.1; -; Genomic_DNA.
DR   EMBL; BC049383; AAH49383.1; -; mRNA.
DR   EMBL; BC050700; AAH50700.1; -; mRNA.
DR   CCDS; CCDS35278.1; -.
DR   RefSeq; NP_001291892.1; NM_001304963.1.
DR   RefSeq; NP_694853.1; NM_153183.3.
DR   UniGene; Hs.375178; -.
DR   PDB; 3MCF; X-ray; 2.00 A; A/B=17-144.
DR   PDBsum; 3MCF; -.
DR   ProteinModelPortal; Q8NFP7; -.
DR   SMR; Q8NFP7; -.
DR   BioGrid; 128079; 3.
DR   IntAct; Q8NFP7; 10.
DR   MINT; MINT-1383448; -.
DR   STRING; 9606.ENSP00000348831; -.
DR   iPTMnet; Q8NFP7; -.
DR   PhosphoSitePlus; Q8NFP7; -.
DR   BioMuta; NUDT10; -.
DR   DMDM; 68565913; -.
DR   EPD; Q8NFP7; -.
DR   MaxQB; Q8NFP7; -.
DR   PaxDb; Q8NFP7; -.
DR   PeptideAtlas; Q8NFP7; -.
DR   PRIDE; Q8NFP7; -.
DR   DNASU; 170685; -.
DR   Ensembl; ENST00000356450; ENSP00000348831; ENSG00000122824.
DR   Ensembl; ENST00000376006; ENSP00000365174; ENSG00000122824.
DR   GeneID; 170685; -.
DR   KEGG; hsa:170685; -.
DR   UCSC; uc004dph.3; human.
DR   CTD; 170685; -.
DR   DisGeNET; 170685; -.
DR   GeneCards; NUDT10; -.
DR   HGNC; HGNC:17621; NUDT10.
DR   HPA; HPA047027; -.
DR   HPA; HPA057684; -.
DR   MIM; 300527; gene.
DR   neXtProt; NX_Q8NFP7; -.
DR   OpenTargets; ENSG00000122824; -.
DR   PharmGKB; PA31831; -.
DR   eggNOG; KOG2839; Eukaryota.
DR   eggNOG; COG0494; LUCA.
DR   GeneTree; ENSGT00390000012928; -.
DR   HOGENOM; HOG000237336; -.
DR   HOVERGEN; HBG053341; -.
DR   InParanoid; Q8NFP7; -.
DR   KO; K07766; -.
DR   OMA; CKANQTR; -.
DR   OrthoDB; EOG091G0TH6; -.
DR   PhylomeDB; Q8NFP7; -.
DR   TreeFam; TF106349; -.
DR   BioCyc; MetaCyc:HS04604-MONOMER; -.
DR   BRENDA; 3.6.1.60; 2681.
DR   Reactome; R-HSA-1855167; Synthesis of pyrophosphates in the cytosol.
DR   ChiTaRS; NUDT10; human.
DR   EvolutionaryTrace; Q8NFP7; -.
DR   GenomeRNAi; 170685; -.
DR   PRO; PR:Q8NFP7; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000122824; -.
DR   CleanEx; HS_NUDT10; -.
DR   Genevisible; Q8NFP7; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0034431; F:bis(5'-adenosyl)-hexaphosphatase activity; IBA:GO_Central.
DR   GO; GO:0034432; F:bis(5'-adenosyl)-pentaphosphatase activity; IBA:GO_Central.
DR   GO; GO:0008486; F:diphosphoinositol-polyphosphate diphosphatase activity; ISS:UniProtKB.
DR   GO; GO:0000298; F:endopolyphosphatase activity; IBA:GO_Central.
DR   GO; GO:0052841; F:inositol bisdiphosphate tetrakisphosphate diphosphatase activity; TAS:Reactome.
DR   GO; GO:0052842; F:inositol diphosphate pentakisphosphate diphosphatase activity; TAS:Reactome.
DR   GO; GO:0052840; F:inositol diphosphate tetrakisphosphate diphosphatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0052846; F:inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0052847; F:inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0052843; F:inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0052848; F:inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0052844; F:inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0052845; F:inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0050072; F:m7G(5')pppN diphosphatase activity; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:1901911; P:adenosine 5'-(hexahydrogen pentaphosphate) catabolic process; IBA:GO_Central.
DR   GO; GO:1901909; P:diadenosine hexaphosphate catabolic process; IBA:GO_Central.
DR   GO; GO:1901907; P:diadenosine pentaphosphate catabolic process; IBA:GO_Central.
DR   GO; GO:0071543; P:diphosphoinositol polyphosphate metabolic process; IBA:GO_Central.
DR   GO; GO:0043647; P:inositol phosphate metabolic process; TAS:Reactome.
DR   InterPro; IPR020084; NUDIX_hydrolase_CS.
DR   InterPro; IPR000086; NUDIX_hydrolase_dom.
DR   InterPro; IPR015797; NUDIX_hydrolase_dom-like.
DR   Pfam; PF00293; NUDIX; 1.
DR   SUPFAM; SSF55811; SSF55811; 1.
DR   PROSITE; PS51462; NUDIX; 1.
DR   PROSITE; PS00893; NUDIX_BOX; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Cytoplasm; Hydrolase; Magnesium;
KW   Manganese; Metal-binding; Reference proteome.
FT   CHAIN         1    164       Diphosphoinositol polyphosphate
FT                                phosphohydrolase 3-alpha.
FT                                /FTId=PRO_0000057062.
FT   DOMAIN       17    144       Nudix hydrolase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00794}.
FT   REGION       17     19       Substrate binding. {ECO:0000250}.
FT   REGION       89     91       Substrate binding. {ECO:0000250}.
FT   MOTIF        50     71       Nudix box.
FT   ACT_SITE     68     68       Proton acceptor. {ECO:0000250}.
FT   METAL        49     49       Magnesium 1; via carbonyl oxygen.
FT                                {ECO:0000250}.
FT   METAL        65     65       Magnesium 2. {ECO:0000250}.
FT   METAL        65     65       Magnesium 3. {ECO:0000250}.
FT   METAL        69     69       Magnesium 1. {ECO:0000250}.
FT   BINDING       9      9       Substrate. {ECO:0000250}.
FT   BINDING      40     40       Substrate. {ECO:0000250}.
FT   CONFLICT     90     90       K -> E (in Ref. 5; AAH50700).
FT                                {ECO:0000305}.
FT   CONFLICT    135    135       V -> M (in Ref. 5; AAH49383).
FT                                {ECO:0000305}.
FT   STRAND       18     27       {ECO:0000244|PDB:3MCF}.
FT   STRAND       32     37       {ECO:0000244|PDB:3MCF}.
FT   STRAND       39     41       {ECO:0000244|PDB:3MCF}.
FT   STRAND       44     46       {ECO:0000244|PDB:3MCF}.
FT   STRAND       49     51       {ECO:0000244|PDB:3MCF}.
FT   HELIX        58     70       {ECO:0000244|PDB:3MCF}.
FT   STRAND       72     83       {ECO:0000244|PDB:3MCF}.
FT   STRAND       92    103       {ECO:0000244|PDB:3MCF}.
FT   HELIX       108    113       {ECO:0000244|PDB:3MCF}.
FT   STRAND      117    121       {ECO:0000244|PDB:3MCF}.
FT   HELIX       122    130       {ECO:0000244|PDB:3MCF}.
FT   HELIX       134    144       {ECO:0000244|PDB:3MCF}.
SQ   SEQUENCE   164 AA;  18500 MW;  589F342E02B285A7 CRC64;
     MKCKPNQTRT YDPEGFKKRA ACLCFRSERE DEVLLVSSSR YPDRWIVPGG GMEPEEEPGG
     AAVREVYEEA GVKGKLGRLL GVFEQNQDPK HRTYVYVLTV TELLEDWEDS VSIGRKREWF
     KVEDAIKVLQ CHKPVHAEYL EKLKLGGSPT NGNSMAPSSP DSDP
//
